Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
@ least I didn't sell America out....🤣
BQ .25 coiling accumulation 4 mill float -> https://stockcharts.com/sc3/ui/?s=BQ
This dummy did! lol
APVO starting here nice chart just beginning to curl up a bit , offering priced in, still 4M float , down from 4 when it split
CZOO was sweet made a quick trade 6.5-8.6 but might go past $20 again?,crypto getting hooter.
$BLEG .0028 golden cross approaching
$CBDL News!!! CBD Life Sciences Provides Update on Exciting Future Following Completion of Reverse Split; Company Poised to Launch Rebranded CBD Products and Online Presence https://finance.yahoo.com/news/cbd-life-sciences-provides-exciting-120000086.html
VERB perking a bit gotta be close to bottom here had a big move bout 6 weeks ago
CZOO..............................MULN.........................................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=3&dy=0&id=p11960084343
https://stockcharts.com/h-sc/ui?s=CZOO&p=D&yr=0&mn=3&dy=0&id=p11960084343
$RTON rebounding, 13 stores, 12 more opening in 2024, Californias Best Brands, low float, tight share structure, increasing revenues, this is a $1pps stock.
$IDGR Travel Zen Timeshares Trend:
Over the last half-decade, the timeshare industry has demonstrated a resilient growth trajectory, with key metrics such as sales volume, rental revenue, and average transaction price not only recovering post-pandemic but indeed showing an upward trend. Despite the initial setbacks faced during the 2020 global health crisis, by 2022, the industry regained momentum, marking a notable rebound in economic contribution and market valuation.
https://wesleyfinancialgroup.com/timeshare-blog/timeshare-statistics/
Z
$RENB: Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care
LOS ANGELES and AMSTERDAM, April 18, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the distinguished Professor Geert Kazemier, MD, PhD, as the new Chairman of its Scientific Advisory Board. This pivotal move signifies a major leap forward in Renovaro’s quest to redefine cancer diagnosis and treatment through cutting-edge AI and immunotherapy technologies.
Professor Kazemier is the Clinical Director and scientific co-director of the Cancer Center at Amsterdam University Medical Center. The center has an extensive repository of biobank tumor material and liquid biopsies, including an extensive range of data from biomarkers, amongst others, for co-rectal, urogenital, lung, and breast cancers.
Professor Kazemier has made groundbreaking contributions to oncology and surgical research. His depth of experience and trailblazing academic and clinical leadership align perfectly with Renovaro's mission. Professor Kazemier's commitment to medical advancement positions him as an ideal leader to propel Renovaro's Scientific Advisory Board during a transformative era in oncology characterized by the integration of Artificial Intelligence.
Under Professor Kazemier’s direction, Amsterdam University Medical Center’s Cancer Center has launched numerous pioneering research projects, substantially enriching our understanding and treatment of cancer. His drive for innovation and excellence echoes Renovaro’s dedication to advancing early diagnosis, accurate response prediction, effective monitoring, and personalized therapy.
As the Chairman of the Scientific Advisory Board, Professor Kazemier is set to influence Renovaro's research and development trajectory. We believe his expertise and forward-thinking approach will guide Renovaro in refining the company's strategic initiatives, including data acquisition and biomarker selection, to position Renovaro at the forefront of innovation. His leadership will prioritize novel research paths with the power to potentially transform cancer diagnosis, monitoring, and treatment processes.
“We are honored to have Professor Kazemier join our team,” remarked Hon Mark Dybul, MD, CEO of Renovaro. “His extraordinary achievements in medical research and visionary leadership are tremendous assets to Renovaro. With Professor Kazemier guiding our Scientific Advisory Board, we are even more confident in our global mission to revolutionize patient care through regenerative medicine.”
Expressing his excitement, Professor Kazemier shared, “I am enthusiastic about playing a role in the evolution of Renovaro's AI platform, 'the Cube,' having witnessed its growth from inception to its current state. I am excited to further contribute to Renovaro’s groundbreaking efforts to reshape the landscape of cancer care. I believe the Cube’s potential to shift cancer patient care from diagnosis to therapy is extraordinary. I eagerly anticipate collaborating with Renovaro’s gifted team to steer the company's research towards transformative medical innovations.”
With Professor Kazemier's appointment, Renovaro cements its status as an AI/biotech frontrunner, ready to drive significant advancements in medical science and enhance patient outcomes in the fight against cancer.
About Renovaro:
Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro includes Renovaro Biosciences with its advanced cell-gene immunotherapy company and Renovaro Cube. Renovaro Cube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. Renovaro Cube intervenes at a stage where potential therapy can be most effective. Renovaro Cube is a molecular data science company with a background in FinTech and a 10-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.
Upon the closing of the previously announced acquisition of Cyclomics (winner of the Health Holland Venture Challenge), Renovaro Cube will be capable of performing liquid biopsies using proprietary technologies to identify single cancer DNA molecules in only one vial of blood. In combination with Oxford Nanopore Technology, genetic information can be retrieved over multiple genetic layers to develop the next generation of cancer diagnostics. This will transform cancer care by enabling faster and more accurate diagnosis throughout the patient journey.
About Prof. Kazemier
Professor Geert Kazemier, MD, PhD, went to medical school and trained as an oncologic and transplant surgeon at Erasmus University Rotterdam, The Netherlands. After a fellowship in hepatobiliary surgery and transplantation at Universitätsklinikum-Eppendorf in Hamburg, Germany, he became a Consultant Hepatobiliary Surgery and Transplantation at Erasmus Medical Center and was later appointed Program Leader of Liver Transplantation there. In 2012, he was appointed as a full hepatobiliary surgery and transplantation professor at Amsterdam University Medical Center. He is currently the Clinical Director and Scientific co-director of Cancer Center Amsterdam at Amsterdam UMC. In his research, he aims to put fundamental research to work in clinical practice as he focuses on developing biomarkers for pancreatic and bile duct cancer and investigating the added value of Artificial Intelligence in liver tumors.
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline and platform. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.
For media inquiries, please contact: karen@renovarocube.com
Source: Renovaro Inc.
https://www.globenewswire.com/newsroom/ti?nf=OTA5MTc2OSM2MjA3NjI3IzIxMjA2Nzk=
https://ml.globenewswire.com/media/YjM1MjkzZDUtZGE5Yi00MjI0LWI5M2MtMjcxMGI0YThiNzk1LTExMzIyNTA=/tiny/Renovaro-Biosciences-Inc-.png
Source: Renovaro Biosciences Inc.
IGPK running hard on new filings...
Best Growth Stock's full report breaks through the noise and offers a comprehensive analysis of the $AGBA Group Holding Limited merger with Triller.
https://bestgrowthstocks.com/access-agba-analysis/
Anyone gonna hit ABQQ after its tumble? Looks like volume has steadied. Freefall may be over.
LYT looks like 5s coming that should LYT it up
🔥$LBRG NEWS - Expanding Distribution
https://www.otcmarkets.com/stock/LBRG/news/Enhanced-Inventory-Management-Solutions-to-Meet-Rising-E-Commerce-Demand?id=437736
Bq .25 bottom bounce watch chart -> https://schrts.co/gfMYjaRH
$HHSE NEWS: Hannover House forms InteliMation AI for first major A.I. Animated Feature Production
Press Release | 09/15/2023
(Click on links to view photos)
https://www.accesswire.com/784381/hannover-house-forms-intelimation-ai-for-first-major-ai-animated-feature-production
https://www.otcmarkets.com/stock/HHSE/news/Hannover-House-forms-InteliMation-AI-for-first-major-AI-Animated-Feature-Production?id=414306
JOURNEY TO UTOPIA to begin production in December with A-List Voice & Music Talent
Major launch planned for Cannes and Summer (2024) Theatrical Release
NEW YORK, NY / ACCESSWIRE / September 15, 2023 / InteliMation AI, a newly formed division of indie studio Hannover House, Inc. (OTC PINK:HHSE), has secured a private investment commitment to produce the world's first fully A.I. and CGI generated feature film, the family appeal fantasy film, "Journey to Utopia." Featuring a voice talent cast of Academy Award winning actors and box office stars, the film's visuals will be fully generated using cutting-edge Artificial Intelligence visual rendering, based on producer-supplied scene structure input and character designs.
Director ERIC PARKINSON is targeting a trio of Academy Award winning actors for "JOURNEY TO UTOPIA" - the first-ever fully AI and CGI generated animated feature film. Pictured above: SHIRLEY MACLAINE, FOREST WHITAKER, KIM BASINGER and director ERIC PARKINSON."We have been trying to produce this film for the past ten years," said Eric Parkinson, C.E.O. of Hannover House. "But the visual demands of creating the land of Utopia made the production costs prohibitive and financially risky. That has changed now with the new A.I. technology and our improved strategy to make the film animated as opposed to live-action," he concluded.
"The Artificial Intelligence CGI technology has reached a point where we can create an animated feature that is visually comparable to a $200-million-dollar studio production, but completed for a fraction of the cost and time," said Parkinson. "From script to theatrical DCP, we can produce a major studio quality animated feature in less than eight months."
"The technology from InteliMation should herald in a major paradigm shift in entertainment," said Christian Large, an independent producer and advisor to Hannover House. "High-end animated features will no longer take multiple years and hundreds-of-millions of dollars to produce. This technological breakthrough will enable a broader range of stories to be created and released, which ultimately will help expand the market," he concluded.
The script for "JOURNEY TO UTOPIA" was written by Mike Snyder ("Wildfire") based on a story by Eric Parkinson. The production is in negotiations to secure three Academy Award winning actors as voice talent for the film. Shirley MacLaine is pegged for the role of "Mother Goose;" Forest Whitaker is being pursued to portray the principal antagonist, "Valkerna," and Kim Basinger is being pursued in the role of "Connie Hammonds," the mother of one of the kids who becomes trapped in the land of Utopia.
Pending receipt of a Screen Actors Guild waiver for the production, recording of voice talent is expected to start in late November or early December. A promo reel is planned for the Cannes 2024 festival with a USA Theatrical launch targeted for July 2024.
The world animation market will generate over $411-billion dollars in 2023, according to Statista Research Department - and is expected to grow to over $580-billion by the year 2030. The A.I. fueled software technology pioneered by Hannover House and InteliMation will revolutionize how animated features and television programming are made.
Hannover House and InteliMation are targeting to complete two animated features in 2024, with three set for 2025 and four features per year beginning in 2026. Hannover House will handle the sales representation of the films worldwide, and will coordinate North American theatrical and ancillary sales campaigns with exhibitors, partner studios and major video-on-demand platforms. Hannover House was formed in 1993 and has found success in a variety of indie film distribution arenas, from DVD and VOD distribution to theatrical exhibition.
The release plans for "Journey To Utopia" will follow a traditional model of a wide USA theatrical launch, followed by Video-On-Demand and physical goods (DVDs / BluRay units).
About Eric Parkinson and Hannover House
Eric Parkinson is an indie film distribution veteran of over thirty-five years, best known for his long reigns as CEO of both Hannover House, Inc. and Hemdale Communications. Parkinson has been directly involved with the release of more than 1,500 feature titles, including notable release campaigns for commercial hits including "Terminator," "Highlander 2" and Best Picture Oscar winners "Platoon" and "The Last Emperor." Animated features distributed by Parkinson include three #1 Billboard Magazine Top Selling hits, "Little Nemo: Adventures in Slumberland", "The Magic Voyage" and "The Princess and the Goblin." On the production side, Parkinson has over fifty feature film credits as a Producer or Executive Producer, and just completed his directorial debut with "WILDFIRE: The Legend of the Cherokee Ghost Horse," starring Anne Heche in her final feature release. Hannover House was formed in 1993 as a book publisher, but grew into a top ten Walmart DVD supplier by the mid ‘2000's with dozens of indie releases populating the popular DVD Budget Bins nationwide. The company expanded into theatrical releases, which were a transitional business model to service the growing Video-On-Demand market. Hannover House stopped representing third-party / indie films in 2018 in favor of a business model that focuses resources on the creation of original, high-profile feature productions.
$HHSE BLOG: Good Business Math: How to turn $4-mm in Private Investment & Presales into a $100-MM Revenue Stream
Friday, September 15, 2023
(Click on link to view photos)
http://hannoverhousemovies.blogspot.com/2023/09/good-business-math-how-to-turn-4-mm-in.html
Greetings HHSE Friends & Followers - We cannot stress how material and monumental the news of today is: that we are going to be the FIRST production company to make a fully CGI - Artifical Intelligence generated animated feature with JOURNEY TO UTOPIA.
For decades, Disney, Pixar, Fox and Universal / Amblin have controlled the $400+BILLION annual world animation market - due to the obstacles of the HUGE production costs and multi-year schedules that animated features have traditionally required. That all goes away with the advent of Ultra-HD quality AI generated animation, following top-shelf character designs, scene structures and built atop a solid script with Academy Award level voice actors.
Suddenly, a (currently) small company like Hannover House (and our new INTELIMATION AI division) can produce a film that looks and feels comparable to the top studio releases.
But we can do it for $4-million and finish it in less than 8-months. Best of all, the production costs are fully covered by production incentives, bank gap credit and private investors... so HHSE does not have to struggle to find capital or dilute the company's share structure with stock issuances.
This is a seminal moment in the company, and one that will be further enhanced by our uplist filings and the MyFlix division.
Get ready, friends. It's going to be an exciting ride!
Hannover House forms InteliMation AI for first major A.I. Animated Feature Production
JOURNEY TO UTOPIA to begin production in December with A-List Voice & Music Talent
Major launch planned for Cannes and Summer (2024) Theatrical Release
New York, NY - InteliMation AI, a newly formed division of indie studio Hannover House, Inc. (OTC: HHSE), has secured a private investment commitment to produce the world’s first fully A.I. and CGI generated feature film, the family appeal fantasy film, “Journey to Utopia.” Featuring a voice talent cast of Academy Award winning actors and box office stars, the film’s visuals will be fully generated using cutting-edge Artificial Intelligence visual rendering, based on producer-supplied scene structure input and character designs.
“We have been trying to produce this film for the past ten years,” said Eric Parkinson, C.E.O. of Hannover House. “But the visual demands of creating the land of Utopia made the production costs prohibitive and financially risky. That has changed now with the new A.I. technology and our improved strategy to make the film animated as opposed to live-action,” he concluded.
“The Artificial Intelligence CGI technology has reached a point where we can create an animated feature that is visually comparable to a $200-million-dollar studio production, but completed for a fraction of the cost and time,” said Parkinson. “From script to theatrical DCP, we can produce a major studio quality animated feature in less than eight months.”
“The technology from InteliMation should herald in a major paradigm shift in entertainment,” said Christian Large, an independent producer and advisor to Hannover House. “High-end animated features will no longer take multiple years and hundreds-of-millions of dollars to produce. This technological breakthrough will enable a broader range of stories to be created and released, which ultimately will help expand the market,” he concluded.
The script for “JOURNEY TO UTOPIA” was written by Mike Snyder (“Wildfire”) based on a story by Eric Parkinson. The production is in negotiations to secure three Academy Award winning actors as voice talent for the film. Shirley MacLaine is pegged for the role of “Mother Goose;” Forest Whitaker is being pursued to portray the principal antagonist, “Valkerna,” and Kim Basinger is being pursued in the role of “Connie Hammonds,” the mother of one of the kids who becomes trapped in the land of Utopia.
Pending receipt of a Screen Actors Guild waiver for the production, recording of voice talent is expected to start in late November. A promo reel is planned for the Cannes 2024 festival with a USA Theatrical launch targeted for July 2024.
The world animation market will generate over $411-billion dollars in 2023, according to Statista Research Department – and is expected to grow to over $580-billion by the year 2030. The A.I. fueled software technology pioneered by Hannover House and InteliMation will revolutionize how animated features and television programming are made.
Hannover House and InteliMation are targeting to complete two animated features in 2024, with three set for 2025 and four features per year beginning in 2026. Hannover House will handle the sales representation of the films worldwide, and will coordinate North American theatrical and ancillary sales campaigns with exhibitors, partner studios and major video-on-demand platforms. Hannover House was formed in 1993 and has found success in a variety of indie film distribution arenas, from DVD and VOD distribution to theatrical exhibition.
The release plans for “Journey To Utopia” will follow a traditional model of a wide USA theatrical launch, followed by Video-On-Demand and physical goods (DVDs / BluRay units).
About Eric Parkinson and Hannover House
Eric Parkinson is an indie film distribution veteran of over thirty-five years, best known for his long reigns as CEO of both Hannover House, Inc. and Hemdale Communications. Parkinson has been directly involved with the release of more than 1,500 feature titles, including notable release campaigns for commercial hits including “Terminator,” “Highlander 2” and Best Picture Oscar winners “Platoon” and “The Last Emperor.” Animated features distributed by Parkinson include three #1 Billboard Magazine Top Selling hits, “Little Nemo: Adventures in Slumberland”, “The Magic Voyage” and “The Princess and the Goblin.” On the production side, Parkinson has over fifty feature film credits as a Producer or Executive Producer, and just completed his directorial debut with “WILDFIRE: The Legend of the Cherokee Ghost Horse,” starring Anne Heche in her final feature release. Hannover House was formed in 1993 as a book publisher, but grew into a top ten Walmart DVD supplier by the mid ‘2000’s with dozens of indie releases populating the popular DVD Budget Bins nationwide. The company expanded into theatrical releases, which were a transitional business model to service the growing Video-On-Demand market. Hannover House stopped representing third-party / indie films in 2018 in favor of a business model that focuses resources on the creation of original, high-profile feature productions.
$HHSE_NEWS:..Resumption of S.E.C...Edgar-Filings Signals-Uplist-Movement for HHSE
Press Release | 01/05/2024
https://www.otcmarkets.com/stock/HHSE/news/Resumption-of-SEC-Edgar-Filings-Signals-Uplist-Movement-for-HHSE?id=426334
Hannover House, Inc. (OTC: HHSE) resumed regular corporate filings and disclosures with the S.E.C. Edgar Database today, signaling the company's movement into fully reporting status and the imminent uplist application for the OTC: QB markets. Hannover House has been operating as a public company since December 2009, listed on the OTC Pinksheets markets. The actions to become fully reporting and to uplist to the OTC: QB market signal the beginning of a significant new phase in the company's growth and activities.
"We anticipate a very positive 2024," said Hannover House C.E.O., Eric Parkinson. "We are thankful for the support of our shareholders over the years, and look forward to moving the company to the next level."
For more information contact: ERIC PARKINSON, 818-481-5277
HHSE SEC FILING (Form-8)
https://www.sec.gov/edgar/browse/?CIK=1069680&owner=exclude
$HHSE-NEWS:..2023 Annual-Report---Re-Formatted & Re-Filed. The removal of the Yield sign (restoration of Current Info), the filings of the audited financials & the OTCQB uplist are next. ALL expected in the coming days. 10x to 100x ROI imminent upon audits, uplist, official launch of MYFLIX (15,000+ streaming movies) and MEGA-announcements/news/productions.
https://www.otcmarkets.com/otcapi/company/financial-report/398058/content
$BLGO EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC
https://finance.yahoo.com/news/epa-adds-pfas-cercla-superfund-123000630.html
$RTON News- Right on Brands Announces Major Product Line Expansion via HONEY® Brands ( 13 stores with 12 more in 2024)
https://www.otcmarkets.com/stock/RTON/news/story?e&id=2826999
$PHRRF Huge news! PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
https://finance.yahoo.com/news/pharmather-provides-priority-original-abbreviated-200000620.html
$SOPA NOW TRADING NEAR ALL TIME LOWS---ANALYST PT=$4
IT'S MONEY TIME---OPPORTUNITY IS KNOCKING HERE
https://thesocietypass.com/
$NCL @Northann_Corp Announces Cross-Licensing Agreement with I4F for Digital Printing Technology https://finance.yahoo.com/news/northann-corp-announces-cross-licensing-120000885.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance $MSFT #3Dprinting $AMD $AI
ZCMD......RZLT.......HWH.......OPRT......MULN.......https://stockcharts.com/h-sc/ui?s=RZLT&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=ZCMD&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=HWH&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=OPRT&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
$ASTI New Spacecraft Projects using Advanced Solar Technology; Partnership between Ascent Solar Technologies, Inc NASDAQ: ASTI @AscentSolar https://www.einpresswire.com/article/704169987/new-spacecraft-projects-using-advanced-solar-technology-partnership-between-ascent-solar-technologies-inc-nasdaq-asti via @ein_news @Nasdaq $MNTS $GDHG $NRXP $CLSK $TSLA
Lotto play #stocktobuy $VGLS Volume precedes price action. stay tuned!
$CBDW @CBDWInc is 100% moving into other verticals, expanding the product line & starting with the #financial industry. #ArtificialIntelligence #ChatCBDW #chatbots http://cbdw.ai
$AGBA Seeking Alpha Article April 22, 2024 - AGBA Group: Triller Merger Creates Significant Speculative Upside If TikTok Gets Banned In The U.S.
https://seekingalpha.com/article/4685179-agba-group-triller-merger-creates-significant-speculative-upside-if-tiktok-gets-banned-in-the-us $MSFT $AI
$AGBA/TRILLER $4 billion MERGER:
OVER $750M DOLLAR VOLUME IN THE LAST TWO SESSIONS
ELEVATING SHAREHOLDER VALUE TO NEW HEIGHTS - IMMEDIATELY AND FOR THE LONG TERM
#triller #TikTok
download #triller app today .
https://t.co/U7t9olFarm
$AGBA Seeking Alpha Article April 22, 2024
AGBA Group: Triller Merger Creates Significant Speculative Upside If TikTok Gets Banned In The U.S.
https://seekingalpha.com/article/4685179-agba-group-triller-merger-creates-significant-speculative-upside-if-tiktok-gets-banned-in-the-us
#OTCQB: $BIDCF / $BITK. TSXV / Frankfurt Börse: $KRL2 https://linkedin.com/pulse/imagine-world-where-transactions-transparent-secure-immutable-sonoga-l1nwc/
@ipoguy
🚨 $VPRB - OTCQB
🗞️ Press Release - VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023
🔗 https://otcmarkets.com/stock/VPRB/news/?id=437435
- wholesaler/licensor of vapes, accessories, and other CBD products.
- wholesale business is breakeven, but growing
- licensing segment did $2.7M in revenue last quarter mostly from their Elf Brand, will probably stabilize
+160% @ 3.25 from 1.25 yesterday, still running. $AGBA
$LTNC More Insider Buying ~ Luis Sequeira, Director.
$LTNC More Insider Buying ~ Luis Sequeira, Director.https://t.co/ARGiLD70dr
— 💸 Golden Cross Stocks 💸 (@CrossStocks) April 23, 2024
Labor Smart, Inc./ LTNC CUSIP 50541A108 OFFICER/DIRECTOR/AFFILIATE STOCK
TRANSACTIONS On 4/22/24, Luis Sequeira, Director of Labor Smart, Inc., acquired 2,999,700 common shares of LTNC on the open…
$IBRX MASSIVE FDA APPROVAL AFTER CLOSE
AGBA.....POET.....NKGN.....NKTR.....BTBT...................https://stockcharts.com/h-sc/ui?s=AGBA&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=POET&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=NKGN&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=NKTR&p=D&yr=0&mn=2&dy=12&id=p84071410134
https://stockcharts.com/h-sc/ui?s=BTBT&p=D&yr=0&mn=2&dy=12&id=p84071410134
Boom $BLLB for the win $$
IGPK closed green -- expected to become current soon!!!
Followers
|
9995
|
Posters
|
|
Posts (Today)
|
7
|
Posts (Total)
|
4972674
|
Created
|
01/10/04
|
Type
|
Free
|
Moderator i_like_bb_stock | |||
Assistants koolmc MOMO vantillian Rainer StockRocket |
![]() | Goal: TO PROVIDE A FORUM FOR BOTH EXPERIENCED AND NOVICE TRADERS TO SHARE THEIR OPINIONS ON STOCKS TRADED ON THE BULLETIN BOARD OR PINK SHEET MARKETS, AS WELL AS THE BIG BOARDS. FUNDAMENTALS, NEWS, RUMORS ARE WELCOME, BUT FOR THE MOST PART, THIS BOARD WILL BE TO SHARE TECHNICAL ANALYSIS. TIMING IS EVERYTHING WHEN BUYING OR SELLING A STOCK, AND TECHNICAL ANALYSIS CAN OFTEN DETERMINE THE APPROPRIATE ACTION TO TAKE. ALL TECHNICAL INDICATORS ARE WELCOME. FOR NOVICE TRADERS, QUESTIONS ARE WELCOMED, AND SOMEONE WILL TRY AND HELP YOU WITH THE ANSWER. I WAS ONCE A NOVICE TRADER, AND KNOW THAT GUIDANCE WOULD HAVE HELPED ME SEVERAL YEARS AGO, SO I WOULD LIKE TO HELP YOU AS MUCH AS POSSIBLE. -- i_like_bb_stock | ![]() |
Rules:1) Spam of any kind will not be tolerated2) There will be times when posters are not in agreement, that is healthy, but please no personal attacks. 3) No specific price preference for the board but these are mostly OTC stocks. 4) Volume is the blood in a stock's veins, so I typically prefer stocks with historical volume, otherwise there is little liquidity for selling the stock if need be. 5) Posting charts and annotations if you have a service that provides it are highly welcome since this provides support for your buy/sell/hold signal. 6) As always, do your due diligence, and remember that there is high risk in these types of stocks. Never trade with money that you cannot afford to loose. 7) If the post is Off Topic, please post with OT prefacing the post. | ![]() |
![]() | Some relevent info:1) For SEC filings I use www.otcmarkets.com.2) For daily charts I use www.stockcharts.com. There is a free service which is time delayed, and then different levels of paid service. 3) To post a chart from stockcharts.com, right click on the chart, click "Copy Image URL". Within the post, right click and click Paste. Remove "http://" then place the chart URL between these tags [*chart]URL[*/chart] (remove the asterisks) 4) For level II, there are various services, IHUB has its own services, individual brokers as well, I use TDAmeritrade, which offers free level II if you have an account. 5) I use equityfeed.com which is critical for any otc trader. It has level II as well, real time news, scanning, and a plethora of things that are needed as a trader. There are various price points based on your needs. 6) For a great listing of stock terms or investor information, use www.investopedia.com or www.investorwords.com. 7) For more info on chart formations, see http://www.chartpatterns.com and http://thepatternsite.com. 8) To find splits, symbol changes etc., use http://otce.finra.org/DailyList 9) Remember also to sell into strength and buy into weakness. When possible, try not to sell at the bid. When a stock is strong, you can usually at least get filled somewhere between the bid/ask, selling at the bid will often hurt the stock, since the market makers make take the bid down further afterwards. 10) For info on stockcharts.com, see the Stockcharts board on the Hub: http://www.investorshub.com/boards/board.asp?board_id=1277 |
Posts Today
|
7
|
Posts (Total)
|
4972674
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |